US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
JPS6098584A
(ja)
|
1983-11-02 |
1985-06-01 |
Canon Inc |
カメラ―体形vtr
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
IL89220A
(en)
|
1988-02-11 |
1994-02-27 |
Bristol Myers Squibb Co |
Immunoconjugates of anthracycline, their production and pharmaceutical preparations containing them
|
WO1991002536A1
(en)
|
1989-08-23 |
1991-03-07 |
Scripps Clinic And Research Foundation |
Compositions and methods for detection and treatment of epstein-barr virus infection and immune disorders
|
US5256643A
(en)
|
1990-05-29 |
1993-10-26 |
The Government Of The United States |
Human cripto protein
|
AU9016591A
(en)
|
1990-10-25 |
1992-05-26 |
Tanox Biosystems, Inc. |
Glycoproteins associated with membrane-bound immunoglobulins as antibody targets on B cells
|
US5543503A
(en)
|
1991-03-29 |
1996-08-06 |
Genentech Inc. |
Antibodies to human IL-8 type A receptor
|
US5440021A
(en)
|
1991-03-29 |
1995-08-08 |
Chuntharapai; Anan |
Antibodies to human IL-8 type B receptor
|
JP4156662B2
(ja)
|
1991-03-29 |
2008-09-24 |
ジェネンテック・インコーポレーテッド |
ヒトpf4a受容体とその使用
|
JP3050424B2
(ja)
|
1991-07-12 |
2000-06-12 |
塩野義製薬株式会社 |
ヒトエンドセリンリセプター
|
US5264557A
(en)
|
1991-08-23 |
1993-11-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polypeptide of a human cripto-related gene, CR-3
|
US6153408A
(en)
|
1991-11-15 |
2000-11-28 |
Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale |
Altered major histocompatibility complex (MHC) determinant and methods of using the determinant
|
US6011146A
(en)
|
1991-11-15 |
2000-01-04 |
Institut Pasteur |
Altered major histocompatibility complex (MHC) determinant and methods of using the determinant
|
IL107366A
(en)
|
1992-10-23 |
2003-03-12 |
Chugai Pharmaceutical Co Ltd |
Genes coding for megakaryocyte potentiator
|
US5644033A
(en)
|
1992-12-22 |
1997-07-01 |
Health Research, Inc. |
Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment
|
US5801005A
(en)
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
US5869445A
(en)
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
US5773223A
(en)
|
1993-09-02 |
1998-06-30 |
Chiron Corporation |
Endothelin B1, (ETB1) receptor polypeptide and its encoding nucleic acid methods, and uses thereof
|
US5750370A
(en)
|
1995-06-06 |
1998-05-12 |
Human Genome Sciences, Inc. |
Nucleic acid encoding human endothlein-bombesin receptor and method of producing the receptor
|
US5707829A
(en)
|
1995-08-11 |
1998-01-13 |
Genetics Institute, Inc. |
DNA sequences and secreted proteins encoded thereby
|
US20020193567A1
(en)
|
1995-08-11 |
2002-12-19 |
Genetics Institute, Inc. |
Secreted proteins and polynucleotides encoding them
|
JP3646191B2
(ja)
|
1996-03-19 |
2005-05-11 |
大塚製薬株式会社 |
ヒト遺伝子
|
CA2254843A1
(en)
|
1996-05-17 |
1997-11-27 |
Schering Corporation |
Human b-cell antigens, related reagents
|
AU5159798A
(en)
*
|
1996-11-05 |
1998-05-29 |
Bristol-Myers Squibb Company |
Branched peptide linkers
|
US5945511A
(en)
|
1997-02-20 |
1999-08-31 |
Zymogenetics, Inc. |
Class II cytokine receptor
|
US20030185830A1
(en)
|
1997-02-25 |
2003-10-02 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7033827B2
(en)
|
1997-02-25 |
2006-04-25 |
Corixa Corporation |
Prostate-specific polynucleotide compositions
|
US6261791B1
(en)
|
1997-03-10 |
2001-07-17 |
The Regents Of The University Of California |
Method for diagnosing cancer using specific PSCA antibodies
|
US6541212B2
(en)
|
1997-03-10 |
2003-04-01 |
The Regents Of The University Of California |
Methods for detecting prostate stem cell antigen protein
|
DE69824287T2
(de)
|
1997-03-10 |
2005-06-16 |
The Regents Of The University Of California, Oakland |
Prostata stammzell-antigen (psca)
|
US6555339B1
(en)
|
1997-04-14 |
2003-04-29 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human protein-coupled receptors
|
US6319688B1
(en)
|
1997-04-28 |
2001-11-20 |
Smithkline Beecham Corporation |
Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
|
US6890749B2
(en)
|
1997-05-15 |
2005-05-10 |
Abbott Laboratories |
Reagents and methods useful for detecting diseases of the prostate
|
WO1998051824A1
(en)
|
1997-05-15 |
1998-11-19 |
Abbott Laboratories |
Reagents and methods useful for detecting disease of the urinary tract
|
US20030060612A1
(en)
|
1997-10-28 |
2003-03-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US20020034749A1
(en)
|
1997-11-18 |
2002-03-21 |
Billing-Medel Patricia A. |
Reagents and methods useful for detecting diseases of the breast
|
US6110695A
(en)
|
1997-12-02 |
2000-08-29 |
The Regents Of The University Of California |
Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1
|
WO2004031238A2
(en)
|
2002-10-03 |
2004-04-15 |
Mcgill Univeristy |
Antibodies and cyclic peptides which bind cea (carcinoembryonic antigen) and their use as cancer therapeutics
|
JP4603157B2
(ja)
|
1998-03-13 |
2010-12-22 |
ザ バーナム インスティチュート |
種々の選択された器官または組織にホーミングする分子
|
AU4078599A
(en)
|
1998-05-13 |
1999-11-29 |
Epimmune, Inc. |
Expression vectors for stimulating an immune response and methods of using the same
|
US20020187472A1
(en)
|
2001-03-09 |
2002-12-12 |
Preeti Lal |
Steap-related protein
|
US20030064397A1
(en)
|
1998-05-22 |
2003-04-03 |
Incyte Genomics, Inc. |
Transmembrane protein differentially expressed in prostate and lung tumors
|
WO2000012130A1
(en)
|
1998-08-27 |
2000-03-09 |
Smithkline Beecham Corporation |
Rp105 agonists and antagonists
|
JP4689781B2
(ja)
|
1998-09-03 |
2011-05-25 |
独立行政法人科学技術振興機構 |
アミノ酸輸送蛋白及びその遺伝子
|
AU5963699A
(en)
|
1998-10-02 |
2000-04-26 |
Mcmaster University |
Spliced form of (erb)b-2/neu oncogene
|
US6858710B2
(en)
|
1998-12-17 |
2005-02-22 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US6962980B2
(en)
|
1999-09-24 |
2005-11-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US20030091580A1
(en)
|
2001-06-18 |
2003-05-15 |
Mitcham Jennifer L. |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US20020119158A1
(en)
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US6468546B1
(en)
|
1998-12-17 |
2002-10-22 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of ovarian cancer
|
EP1141017B1
(en)
|
1998-12-30 |
2008-09-10 |
Beth Israel Deaconess Medical Center, Inc. |
Characterization of the soc/crac calcium channel protein family
|
NZ513062A
(en)
|
1999-01-29 |
2003-10-31 |
Smithkline Beecham |
HER-2/neu fusion proteins
|
GB9905124D0
(en)
|
1999-03-05 |
1999-04-28 |
Smithkline Beecham Biolog |
Novel compounds
|
US7232889B2
(en)
|
1999-03-08 |
2007-06-19 |
Genentech, Inc. |
PRO300 antibodies
|
AU3395900A
(en)
|
1999-03-12 |
2000-10-04 |
Human Genome Sciences, Inc. |
Human lung cancer associated gene sequences and polypeptides
|
US7304126B2
(en)
|
1999-05-11 |
2007-12-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU4952600A
(en)
|
1999-06-03 |
2000-12-28 |
Takeda Chemical Industries Ltd. |
Screening method with the use of cd100
|
EP1191944A2
(en)
|
1999-06-25 |
2002-04-03 |
Genentech, Inc. |
METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
|
US7589172B2
(en)
|
1999-07-20 |
2009-09-15 |
Genentech, Inc. |
PRO256 polypeptides
|
US7297770B2
(en)
|
1999-08-10 |
2007-11-20 |
Genentech, Inc. |
PRO6496 polypeptides
|
US7294696B2
(en)
|
1999-08-17 |
2007-11-13 |
Genentech Inc. |
PRO7168 polypeptides
|
JP3951035B2
(ja)
|
1999-09-01 |
2007-08-01 |
ジェネンテック・インコーポレーテッド |
分泌及び膜貫通ポリペプチドとそれをコードしている核酸
|
US20030232056A1
(en)
|
1999-09-10 |
2003-12-18 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US20030206918A1
(en)
|
1999-09-10 |
2003-11-06 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US20030129192A1
(en)
|
1999-09-10 |
2003-07-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
DE60039448D1
(de)
|
1999-10-29 |
2008-08-21 |
Genentech Inc |
Gegen das prostata-stammzellantigen (psca) gerichtete antikörper und deren verwendung
|
EP1235847B1
(en)
|
1999-11-29 |
2016-01-20 |
The Trustees of Columbia University in the City of New York |
ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA
|
WO2001040269A2
(en)
|
1999-11-30 |
2001-06-07 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of breast cancer
|
WO2001041787A1
(en)
|
1999-12-10 |
2001-06-14 |
Epimmune Inc. |
INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
|
AU2458001A
(en)
|
1999-12-23 |
2001-07-03 |
Zymogenetics Inc. |
Method for treating inflammation
|
US6610286B2
(en)
|
1999-12-23 |
2003-08-26 |
Zymogenetics, Inc. |
Method for treating inflammation using soluble receptors to interleukin-20
|
NZ502058A
(en)
|
1999-12-23 |
2003-11-28 |
Ovita Ltd |
Isolated mutated nucleic acid molecule for regulation of ovulation rate
|
UA84830C2
(uk)
|
1999-12-23 |
2008-12-10 |
Займодженетікс, Інк. |
Розчинний рецептор інтерлейкіну-20
|
US20040001827A1
(en)
|
2002-06-28 |
2004-01-01 |
Dennis Mark S. |
Serum albumin binding peptides for tumor targeting
|
DE60041564D1
(de)
|
1999-12-24 |
2009-03-26 |
Genentech Inc |
Verfahren und Zusammensetzungen zur Verlängerung der Entsorgungshalbwertszeit von biowirksamen Verbindungen
|
PT1242438E
(pt)
|
1999-12-29 |
2007-02-28 |
Immunogen Inc |
Agentes citotóxicos compreendendo dixorrubicinas e daunorrubicinas modificadas e seu uso terapêutico
|
US7294695B2
(en)
|
2000-01-20 |
2007-11-13 |
Genentech, Inc. |
PRO10268 polypeptides
|
US20020039573A1
(en)
|
2000-01-21 |
2002-04-04 |
Cheever Martin A. |
Compounds and methods for prevention and treatment of HER-2/neu associated malignancies
|
US20030224379A1
(en)
|
2000-01-21 |
2003-12-04 |
Tang Y. Tom |
Novel nucleic acids and polypeptides
|
AU2001243142A1
(en)
|
2000-02-03 |
2001-08-14 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
WO2001062794A2
(en)
|
2000-02-22 |
2001-08-30 |
Millennium Pharmaceuticals, Inc. |
18607, a human calcium channel
|
US20030219806A1
(en)
|
2000-02-22 |
2003-11-27 |
Millennium Pharmaceuticals, Inc. |
Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor
|
US20040005561A1
(en)
|
2000-03-01 |
2004-01-08 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
CA2402293A1
(en)
|
2000-03-07 |
2001-09-13 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
CA2403637A1
(en)
|
2000-03-24 |
2001-10-04 |
Fahri Saatcioglu |
Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
|
WO2001072830A2
(de)
|
2000-03-31 |
2001-10-04 |
Ipf Pharmaceuticals Gmbh |
Diagnostik- und arzneimittel zur untersuchung des zelloberflächenproteoms von tumor- und entzündungszellen sowie zur behandlung von tumorerkrankungen und entzündlichen erkrankungen vorzugsweise mit hilfe einer spezifischen chemokinrezeptor-analyse und der chemokinrezeptor-ligand-interaktion
|
AU2001253140A1
(en)
|
2000-04-03 |
2001-10-15 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Tumor markers in ovarian cancer
|
IL152136A0
(en)
|
2000-04-07 |
2003-05-29 |
Arena Pharm Inc |
Non-endogenous, constitutively activated known g protein-coupled receptors
|
US20030119115A1
(en)
|
2000-05-17 |
2003-06-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO2001088133A2
(en)
|
2000-05-18 |
2001-11-22 |
Lexicon Genetics Incorporated |
Human semaphorin homologs and polynucleotides encoding the same
|
AU2001274888A1
(en)
|
2000-05-19 |
2001-12-03 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
WO2001094641A2
(en)
|
2000-06-09 |
2001-12-13 |
Idec Pharmaceuticals Corporation |
Gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas
|
WO2001098351A2
(en)
|
2000-06-16 |
2001-12-27 |
Incyte Genomics, Inc. |
G-protein coupled receptors
|
EP1383892A2
(en)
|
2000-06-30 |
2004-01-28 |
Incyte Genomics, Inc. |
Human extracellular matrix and cell adhesion polypeptides
|
CA2413262A1
(en)
|
2000-06-30 |
2002-01-10 |
Amgen, Inc. |
B7-like molecules and uses thereof
|
CA2406649A1
(en)
|
2000-06-30 |
2002-01-10 |
Human Genome Sciences, Inc. |
B7-like polynucleotides, polypeptides, and antibodies
|
WO2002006339A2
(en)
|
2000-07-03 |
2002-01-24 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
US20040044179A1
(en)
|
2000-07-25 |
2004-03-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU2001283507A1
(en)
|
2000-07-27 |
2002-02-13 |
Mayo Foundation For Medical Education And Research |
B7-h3 and b7-h4, novel immunoregulatory molecules
|
US7205108B2
(en)
|
2000-07-28 |
2007-04-17 |
Ulrich Wissenbach |
Trp8, Trp9 and Trp10, novel markers for cancer
|
US7229623B1
(en)
|
2000-08-03 |
2007-06-12 |
Corixa Corporation |
Her-2/neu fusion proteins
|
AU2001283360A1
(en)
|
2000-08-14 |
2002-02-25 |
Corixa Corporation |
Methods for diagnosis and therapy of hematological and virus-associated malignancies
|
KR20030048009A
(ko)
|
2000-08-14 |
2003-06-18 |
코릭사 코포레이션 |
Her-2/neu 관련 악성 종양의 치료 및 진단용 조성물및 방법
|
KR20030029847A
(ko)
|
2000-08-24 |
2003-04-16 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 조성물 및 방법
|
GB0020953D0
(en)
|
2000-08-24 |
2000-10-11 |
Smithkline Beecham Biolog |
Vaccine
|
CA2421949A1
(en)
|
2000-09-11 |
2002-03-21 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
US7491797B2
(en)
|
2000-09-15 |
2009-02-17 |
Genentech, Inc. |
PRO6308 polypeptide
|
US6613567B1
(en)
|
2000-09-15 |
2003-09-02 |
Isis Pharmaceuticals, Inc. |
Antisense inhibition of Her-2 expression
|
US7855269B2
(en)
|
2000-09-15 |
2010-12-21 |
Zymogenetics, Inc. |
Method for treating inflammation
|
AU2001292724B2
(en)
|
2000-09-18 |
2005-05-26 |
Biogen Idec Ma Inc. |
CRIPTO mutant and uses thereof
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
AU2002215345A1
(en)
|
2000-10-13 |
2002-04-22 |
Eos Biotechnology, Inc. |
Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
|
AU2002230659A1
(en)
|
2000-11-07 |
2002-05-21 |
Zymogenetics Inc. |
Human tumor necrosis factor receptor
|
US20020150573A1
(en)
|
2000-11-10 |
2002-10-17 |
The Rockefeller University |
Anti-Igalpha-Igbeta antibody for lymphoma therapy
|
WO2002061087A2
(en)
|
2000-12-19 |
2002-08-08 |
Lifespan Biosciences, Inc. |
Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
|
AU2002243495A1
(en)
|
2001-01-12 |
2002-07-24 |
University Of Medicine And Dentistry Of New Jersey |
Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
|
US20030119119A1
(en)
|
2001-01-16 |
2003-06-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030119133A1
(en)
|
2001-01-16 |
2003-06-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
AU2002245317A1
(en)
|
2001-01-24 |
2002-08-06 |
Protein Design Labs |
Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
|
AU2002251841A1
(en)
|
2001-01-30 |
2002-08-12 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of pancreatic cancer
|
WO2002064798A1
(en)
|
2001-02-12 |
2002-08-22 |
Bionomics Limited |
Dna sequences differentially expressed in tumour cell lines
|
US20030087250A1
(en)
|
2001-03-14 |
2003-05-08 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
EP1243276A1
(en)
|
2001-03-23 |
2002-09-25 |
Franciscus Marinus Hendrikus De Groot |
Elongated and multiple spacers containing activatible prodrugs
|
AU2002311787A1
(en)
|
2001-03-28 |
2002-10-15 |
Zycos Inc. |
Translational profiling
|
WO2003008537A2
(en)
|
2001-04-06 |
2003-01-30 |
Mannkind Corporation |
Epitope sequences
|
US6820011B2
(en)
|
2001-04-11 |
2004-11-16 |
The Regents Of The University Of Colorado |
Three-dimensional structure of complement receptor type 2 and uses thereof
|
WO2002083866A2
(en)
|
2001-04-17 |
2002-10-24 |
The Board Of Trustees Of The University Of Arkansas |
Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
|
EP1463928A2
(en)
|
2001-04-18 |
2004-10-06 |
Protein Design Labs |
Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
|
RS20110024A
(en)
|
2001-04-26 |
2011-08-31 |
Biogen Idec Ma Inc. |
ANTIBODIES THAT BLOCK CRIPTO AND USE IT
|
WO2003083041A2
(en)
|
2002-03-22 |
2003-10-09 |
Biogen, Inc. |
Cripto-specific antibodies
|
EP1515982A4
(en)
|
2001-05-09 |
2005-10-26 |
Corixa Corp |
METHODS AND COMPOSITIONS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
|
US20030078399A1
(en)
|
2001-05-11 |
2003-04-24 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acid sequence encoding ovarian antigen, CA125, and uses thereof
|
CN1612750B
(zh)
|
2001-05-24 |
2012-10-31 |
津莫吉尼蒂克斯公司 |
Taci-免疫球蛋白融合蛋白质
|
US7157558B2
(en)
|
2001-06-01 |
2007-01-02 |
Genentech, Inc. |
Polypeptide encoded by a polynucleotide overexpresses in tumors
|
AU2002314901A1
(en)
|
2001-06-04 |
2002-12-16 |
Eos Biotechnology, Inc. |
Methods of diagnosis and treatment of androgen-dependent prostate cancer, prostate cancer undergoing androgen-withdrawal, and androgen-independent prostate cancer
|
WO2003000842A2
(en)
|
2001-06-04 |
2003-01-03 |
Curagen Corporation |
Novel proteins and nucleic acids encoding same
|
ATE483976T1
(de)
|
2001-06-05 |
2010-10-15 |
Exelixis Inc |
Gfats als modifikatoren des p53-wegs und verwendungsverfahren
|
AU2002310256A1
(en)
|
2001-06-05 |
2002-12-16 |
Exelixis Inc. |
Ppp2cs as modifiers of the p53 pathway and methods of use
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
WO2002101075A2
(en)
|
2001-06-13 |
2002-12-19 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
|
US7189507B2
(en)
|
2001-06-18 |
2007-03-13 |
Pdl Biopharma, Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
WO2002102235A2
(en)
|
2001-06-18 |
2002-12-27 |
Eos Biotechnology Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
US7705120B2
(en)
|
2001-06-21 |
2010-04-27 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
|
WO2003002717A2
(en)
|
2001-06-28 |
2003-01-09 |
Schering Corporation |
Biological activity of ak155
|
AU2002314433A1
(en)
|
2001-07-02 |
2003-01-21 |
Licentia Ltd. |
Ephrin-tie receptor materials and methods
|
US20040076955A1
(en)
|
2001-07-03 |
2004-04-22 |
Eos Biotechnology, Inc. |
Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
|
WO2003003984A2
(en)
|
2001-07-05 |
2003-01-16 |
Curagen Corporation |
Novel proteins and nucleic acids encoding same
|
WO2003055439A2
(en)
|
2001-07-18 |
2003-07-10 |
The Regents Of The University Of California |
Her2/neu target antigen and use of same to stimulate an immune response
|
WO2003009814A2
(en)
|
2001-07-25 |
2003-02-06 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
|
CA2453995A1
(en)
|
2001-08-03 |
2003-02-20 |
Genentech, Inc. |
Tacis and br3 polypeptides and uses thereof
|
WO2003016475A2
(en)
|
2001-08-14 |
2003-02-27 |
The General Hospital Corporation |
Nucleic acid and amino acid sequences involved in pain
|
US20030092013A1
(en)
|
2001-08-16 |
2003-05-15 |
Vitivity, Inc. |
Diagnosis and treatment of vascular disease
|
WO2003018621A2
(en)
|
2001-08-23 |
2003-03-06 |
Oxford Biomedica (Uk) Limited |
Genes
|
US6902930B2
(en)
|
2001-08-29 |
2005-06-07 |
Vanderbilt University |
Human Mob-5 (IL-24) receptors and uses thereof
|
US20030124579A1
(en)
|
2001-09-05 |
2003-07-03 |
Eos Biotechnology, Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
WO2003022995A2
(en)
|
2001-09-06 |
2003-03-20 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
|
EP1434881A4
(en)
|
2001-09-17 |
2005-10-26 |
Protein Design Labs Inc |
METHOD FOR DIAGNOSIS OF CANCER COMPOSITIONS AND METHOD FOR SCREENING ON CANCER MODULATORS
|
US20050004017A1
(en)
|
2001-09-18 |
2005-01-06 |
Yuval Reiss |
Methods and compositions for treating hcap associated diseases
|
KR101008758B1
(ko)
|
2001-09-18 |
2011-01-14 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
|
CA2460621A1
(en)
|
2001-09-19 |
2003-03-27 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
WO2003026493A2
(en)
|
2001-09-28 |
2003-04-03 |
Bing Yang |
Diagnosis and treatment of diseases caused by mutations in cd72
|
AU2002362454A1
(en)
|
2001-10-03 |
2003-04-14 |
Origene Technologies, Inc. |
Regulated breast cancer genes
|
US20050130117A1
(en)
|
2001-10-03 |
2005-06-16 |
Davis Cong L. |
Modulators of lymphocyte activation and migration
|
US20040241703A1
(en)
|
2002-08-19 |
2004-12-02 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US20050123925A1
(en)
|
2002-11-15 |
2005-06-09 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
EP1578385A4
(en)
|
2001-10-19 |
2011-11-09 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF INFLAMMATORY INTESTINAL DISEASES
|
US7825089B2
(en)
|
2001-10-24 |
2010-11-02 |
National Jewish Health |
Three-dimensional structures of TALL-1 and its cognate receptors and modified proteins and methods related thereto
|
DE60217152T2
(de)
|
2001-10-31 |
2007-10-31 |
Alcon Inc. |
Knochen-morphogene proteine (bmp), bmp-rezeptoren und bmp-bindungsproteine und ihre verwendung bei der diagnose und behandlung des glaukoms
|
WO2003042661A2
(en)
|
2001-11-13 |
2003-05-22 |
Protein Design Labs, Inc. |
Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
|
US20030232350A1
(en)
|
2001-11-13 |
2003-12-18 |
Eos Biotechnology, Inc. |
Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
|
US7344843B2
(en)
|
2001-11-29 |
2008-03-18 |
Serono Genetics Institute S.A. |
Agonists and antagonists of prolixin for the treatment of metabolic disorders
|
AU2002349784A1
(en)
|
2001-12-03 |
2003-06-17 |
Asahi Kasei Pharma Corporation |
Nf-kappab activating genes
|
AU2002366951A1
(en)
|
2001-12-10 |
2003-07-09 |
Nuvelo,Inc. |
Novel nucleic acids and polypeptides
|
US20030134790A1
(en)
|
2002-01-11 |
2003-07-17 |
University Of Medicine And Dentistry Of New Jersey |
Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer
|
US7452675B2
(en)
|
2002-01-25 |
2008-11-18 |
The Queen's Medical Center |
Methods of screening for TRPM4b modulators
|
AU2003224624B2
(en)
|
2002-02-21 |
2008-08-28 |
Duke University |
Reagents and treatment methods for autoimmune diseases
|
EP1575480A4
(en)
|
2002-02-22 |
2008-08-06 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO THE IMMUNE SYSTEM
|
WO2003083047A2
(en)
|
2002-03-01 |
2003-10-09 |
Exelixis, Inc. |
MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
|
WO2003104399A2
(en)
|
2002-06-07 |
2003-12-18 |
Avalon Pharmaceuticals, Inc |
Cancer-linked gene as target for chemotherapy
|
EP2258712A3
(en)
|
2002-03-15 |
2011-05-04 |
Multicell Immunotherapeutics, Inc. |
Compositions and Methods to Initiate or Enhance Antibody and Major-histocompatibility Class I or Class II-restricted T Cell Responses by Using Immunomodulatory, Non-coding RNA Motifs
|
WO2004000997A2
(en)
|
2002-03-19 |
2003-12-31 |
Curagen Corporation |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US7202033B2
(en)
|
2002-03-21 |
2007-04-10 |
Sunesis Pharmaceuticals, Inc. |
Identification of kinase inhibitors
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
AU2003245239A1
(en)
|
2002-03-25 |
2003-11-03 |
Uab Research Foundation |
FC receptor homolog, reagents, and uses thereof
|
AU2003222103A1
(en)
|
2002-03-28 |
2003-10-13 |
Idec Pharmaceuticals Corporation |
Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas
|
US20030194704A1
(en)
|
2002-04-03 |
2003-10-16 |
Penn Sharron Gaynor |
Human genome-derived single exon nucleic acid probes useful for gene expression analysis two
|
BR0308953A
(pt)
|
2002-04-05 |
2006-03-14 |
Agensys Inc |
composições, proteìna, polinucleotìdeo, método de geração de uma resposta imune, método de detecção, composição farmacêutica, anticorpo ou seu fragmento, animal transgênico, hibridoma, método de fornecimento de um agente citotóxico ou agente de diagnóstico e método de inibição do crescimento de células cancerosas
|
WO2003087768A2
(en)
|
2002-04-12 |
2003-10-23 |
Mitokor |
Targets for therapeutic intervention identified in the mitochondrial proteome
|
JP2005536190A
(ja)
|
2002-04-16 |
2005-12-02 |
ジェネンテック・インコーポレーテッド |
腫瘍の診断と治療のための組成物と方法
|
WO2003089904A2
(en)
|
2002-04-17 |
2003-10-30 |
Baylor College Of Medicine |
Aib1 as a prognostic marker and predictor of resistance to encocrine therapy
|
WO2003093444A2
(en)
|
2002-05-03 |
2003-11-13 |
Incyte Corporation |
Transporters and ion channels
|
AU2003229294A1
(en)
|
2002-05-15 |
2003-12-02 |
Avalon Pharmaceuticals |
Cancer-linked gene as target for chemotherapy
|
AU2003232453A1
(en)
|
2002-05-30 |
2003-12-19 |
David K. Bol |
Human solute carrier family 7 member 11 (hslc7a11)
|
CA2488284A1
(en)
|
2002-06-04 |
2003-12-11 |
Avalon Pharmaceuticals, Inc. |
Cancer-linked gene as target for chemotherapy
|
WO2003101283A2
(en)
|
2002-06-04 |
2003-12-11 |
Incyte Corporation |
Diagnostics markers for lung cancer
|
AU2003242633A1
(en)
|
2002-06-06 |
2003-12-22 |
Molecular Engines Laboratories |
Dudulin genes, non-human animal model: uses in human hematological disease
|
BRPI0311822B8
(pt)
|
2002-06-06 |
2021-05-25 |
Oncotherapy Science Inc |
composição farmacêutica para o tratamento de câncer
|
WO2003105758A2
(en)
|
2002-06-12 |
2003-12-24 |
Avalon Pharmaceuticals, Inc. |
Cancer-linked gene as target for chemotherapy
|
EP1552002A4
(en)
|
2002-06-18 |
2006-02-08 |
Archemix Corp |
APTAMER TOXIN MOLECULES AND METHOD FOR THEIR USE
|
US20040249130A1
(en)
|
2002-06-18 |
2004-12-09 |
Martin Stanton |
Aptamer-toxin molecules and methods for using same
|
AU2003245615A1
(en)
|
2002-06-20 |
2004-01-06 |
The Regents Of The University Of California |
Compositions and methods for modulating lymphocyte activity
|
EP1534331B1
(en)
|
2002-06-21 |
2014-10-29 |
Johns Hopkins University School of Medicine |
Membrane associated tumor endothelium markers
|
AU2003281515A1
(en)
|
2002-07-19 |
2004-02-09 |
Cellzome Ag |
Protein complexes of cellular networks underlying the development of cancer and other diseases
|
WO2004011611A2
(en)
|
2002-07-25 |
2004-02-05 |
Genentech, Inc. |
Taci antibodies and uses thereof
|
WO2004015426A1
(en)
|
2002-08-06 |
2004-02-19 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5)
|
JP2004121218A
(ja)
|
2002-08-06 |
2004-04-22 |
Jenokkusu Soyaku Kenkyusho:Kk |
気管支喘息または慢性閉塞性肺疾患の検査方法
|
EP1572957A4
(en)
|
2002-08-27 |
2007-10-10 |
Bristol Myers Squibb Pharma Co |
IDENTIFICATION OF POLYNUCLEOTIDES FOR PREDICTING THE ACTIVITY OF COMPOUNDS INTERACTING WITH AND / OR MODULATING TYROSINE KINASE PROTEINS AND / OR TYROSINE KINASE PROTEIN PATHWAYS IN MAMMARY CELLS
|
WO2004020595A2
(en)
|
2002-08-29 |
2004-03-11 |
Five Prime Therapeutics, Inc. |
Novel human polypeptides encoded by polynucleotides
|
AU2002951346A0
(en)
|
2002-09-05 |
2002-09-26 |
Garvan Institute Of Medical Research |
Diagnosis of ovarian cancer
|
MXPA05002455A
(es)
|
2002-09-06 |
2005-06-03 |
Mannkind Corp |
Secuencias de epitopes.
|
AU2003300776A1
(en)
|
2002-09-09 |
2004-05-25 |
Omeros Corporation |
G protein coupled receptors and uses thereof
|
JP2004113151A
(ja)
|
2002-09-27 |
2004-04-15 |
Sankyo Co Ltd |
癌遺伝子及びその用途
|
US20060183120A1
(en)
|
2002-10-04 |
2006-08-17 |
Teh Bin T |
Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers
|
WO2004042017A2
(en)
|
2002-10-31 |
2004-05-21 |
Genentech, Inc. |
Methods and compositions for increasing antibody production
|
ZA200503075B
(en)
*
|
2002-11-07 |
2006-09-27 |
Immunogen Inc |
Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same
|
CA2503748A1
(en)
|
2002-11-08 |
2004-05-27 |
Genentech, Inc. |
Compositions and methods for the treatment of natural killer cell related diseases
|
CA2503621A1
(en)
|
2002-11-13 |
2004-05-27 |
Genentech, Inc. |
Methods and compositions for diagnosing dysplasia
|
EP1578372A4
(en)
|
2002-11-15 |
2007-10-17 |
Univ Arkansas |
CA125 GENE AND ITS USE IN DIAGNOSTIC AND THERAPEUTIC INTERVENTIONS
|
EP1569685B8
(en)
|
2002-11-15 |
2012-12-05 |
MUSC Foundation For Research Development |
Complement receptor 2 targeted complement modulators
|
US20080213166A1
(en)
|
2002-11-20 |
2008-09-04 |
Biogen Idec Inc. |
Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas
|
CA2507044A1
(en)
|
2002-11-21 |
2004-06-10 |
Mary Lucero |
Purinergic modulation of smell
|
US20040253606A1
(en)
|
2002-11-26 |
2004-12-16 |
Protein Design Labs, Inc. |
Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
|
WO2004053079A2
(en)
|
2002-12-06 |
2004-06-24 |
Diadexus, Inc. |
Compositions, splice variants and methods relating to ovarian specific genes and proteins
|
JP2004198419A
(ja)
|
2002-12-13 |
2004-07-15 |
Bayer Healthcare Llc |
Timp1を用いた検出方法
|
DK1572748T3
(da)
*
|
2002-12-17 |
2010-08-23 |
Merck Patent Gmbh |
Humaniseret antistof (H14.18) af muse-14.18-antistof der binder til GD2 og dets fusionsprotein med IL-2
|
ES2388280T3
(es)
|
2002-12-20 |
2012-10-11 |
Abbott Biotherapeutics Corp. |
Anticuerpos que reaccionan frente a GPR64 y utilización de los mismos
|
AU2003299819A1
(en)
|
2002-12-23 |
2004-07-22 |
Human Genome Sciences, Inc. |
Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof
|
WO2004063709A2
(en)
|
2003-01-08 |
2004-07-29 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
|
US20050181375A1
(en)
|
2003-01-10 |
2005-08-18 |
Natasha Aziz |
Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
|
US20050227301A1
(en)
|
2003-01-10 |
2005-10-13 |
Polgen |
Cell cycle progression proteins
|
EP1583820A4
(en)
|
2003-01-14 |
2007-07-18 |
Bristol Myers Squibb Co |
ASSOCIATED POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-KB WAY
|
JP2007520996A
(ja)
|
2003-01-15 |
2007-08-02 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
44390、54181、211、5687、884、1405、636、4421、5410、30905、2045、16405、18560、2047、33751、52872、14063、20739、32544、43239、44373、51164、53010、16852、1587、2207、22245、2387、52908、69112、14990、18547、115、579、15985、15625、760、18603、2395、2554、8675、32720、4809、14303、16816、17827、32620、577、619、1423、2158、8263、15402、16209、16386、21165、30911、41897、1643、2543、9626、13231、32409、84260、2882、8203、32678または55053を用いて泌尿器科障害を処置するための方法および組成物
|
WO2004065417A2
(en)
|
2003-01-23 |
2004-08-05 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
CA2516128A1
(en)
|
2003-02-14 |
2004-09-02 |
Sagres Discovery, Inc. |
Therapeutic targets in cancer
|
US20030224411A1
(en)
|
2003-03-13 |
2003-12-04 |
Stanton Lawrence W. |
Genes that are up- or down-regulated during differentiation of human embryonic stem cells
|
SG195524A1
(en)
|
2003-11-06 |
2013-12-30 |
Seattle Genetics Inc |
Monomethylvaline compounds capable of conjugation to ligands
|
SI1791565T1
(sl)
|
2004-09-23 |
2016-08-31 |
Genentech, Inc. |
Cisteinsko konstruirana protitelesa in konjugati
|
KR101103108B1
(ko)
|
2005-06-20 |
2012-01-04 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 조성물 및 방법
|
WO2007008603A1
(en)
*
|
2005-07-07 |
2007-01-18 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine side-chain modifications at the c-terminus
|
RS54163B1
(en)
|
2006-05-30 |
2015-12-31 |
Genentech Inc. |
ANTI-CD22 ANTIBODIES, THEIR IMMUNCONJUGATES AND THEIR USE
|
CA2683568A1
(en)
|
2007-05-08 |
2008-11-20 |
Genentech, Inc. |
Cysteine engineered anti-muc16 antibodies and antibody drug conjugates
|
US8937161B2
(en)
|
2007-10-19 |
2015-01-20 |
Genentech, Inc. |
Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates
|
US8742076B2
(en)
|
2008-02-01 |
2014-06-03 |
Genentech, Inc. |
Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
|
AR072804A1
(es)
*
|
2008-07-15 |
2010-09-22 |
Genentech Inc |
Conjugados derivados de antraciclina,proceso para su preparacion,composiciones farmaceuticas que los contienen y su uso como agentes antitumorales.
|
CN103826661B
(zh)
*
|
2011-04-21 |
2019-03-05 |
西雅图基因公司 |
新的结合剂-药物缀合物(adc)及其用途
|
AR090549A1
(es)
*
|
2012-03-30 |
2014-11-19 |
Genentech Inc |
Anticuerpos anti-lgr5 e inmunoconjugados
|
AR090903A1
(es)
*
|
2012-05-01 |
2014-12-17 |
Genentech Inc |
Anticuerpos e inmunoconjugados anti-pmel17
|
AR091098A1
(es)
*
|
2012-05-21 |
2015-01-14 |
Genentech Inc |
ANTICUERPOS E INMUNOCONJUGADOS CONTRA Ly6E Y METODOS DE USO
|
MX2015004757A
(es)
*
|
2012-10-16 |
2015-07-17 |
Endocyte Inc |
Conjugados de suministro de farmacos que contienen aminoacidos no naturales y metodo para usarlos.
|
CN107106700B
(zh)
|
2013-12-16 |
2020-10-30 |
基因泰克公司 |
肽模拟化合物及其抗体-药物缀合物
|
JP6681838B2
(ja)
|
2013-12-16 |
2020-04-15 |
ジェネンテック, インコーポレイテッド |
ペプチド模倣薬化合物及びその抗体−薬剤複合体
|
AU2015358532C1
(en)
|
2014-12-03 |
2020-10-29 |
Genentech, Inc. |
Quaternary amine compounds and antibody-drug conjugates thereof
|